SOL-01 · Solutions · Pharmaceutical Manufacturing
Launch production sooner — with audit traceability you never have to reconstruct.
A new pharmaceutical facility or line is a nine-figure commitment with a launch date the whole business plans around. Between mechanical completion and released product stands the full weight of CQV: thousands of qualification tests, FDA and EMA scrutiny, and a documentation record that must be flawless not once, but permanently.
The struggle
What makes readiness hard here
Qualification complexity
IQ, OQ and PQ across hundreds of systems, with protocols, matrices and traceability managed in documents that were never designed to carry this load.
Inspection exposure
An FDA pre-approval inspection can stall a launch over documentation gaps — not because the work wasn't done, but because it can't be proven quickly.
Startup slippage
Every week between mechanical completion and release is carried at the cost of an idle validated facility — while batch revenue waits.
The reporting tax
Senior engineers spending their evenings updating trackers and building slide decks instead of closing out systems.
The opportunity
Where the leverage is
The qualification workload itself is largely fixed — regulation defines it. What is not fixed is the coordination tax around it: the re-typing, the matrix rebuilding, the signature chasing, the evidence hunting, the weekly status archaeology. Digitising the thread from requirement to handover removes most of that tax and, more importantly, makes the true state of qualification visible while there is still time to act on it.
With Rowsys
What changes
- Traceability that maintains itself
- Every requirement mapped to systems, tests and evidence automatically — a pre-approval inspection trace produced in seconds. Traceability Engine
- Execution at the equipment
- Protocols executed on tablets in the cleanroom and plant room, with results, photos and GDP-compliant entries captured at the point of work. Mobile Execution
- Part 11 approvals in the flow
- Electronic signatures replace the print-sign-scan cycle, cutting approval cycles from weeks to days. Electronic Approvals
- A startup date you can defend
- Live readiness by system and area — the number the steering committee sees is the number the field produced today. Readiness Dashboards
Outcomes
What you get
- Production launched sooner, with the qualification record complete on day one
- Inspection questions answered in seconds from the live system
- Senior engineers doing engineering, not administration
- One version of readiness truth from the field to the boardroom
Not sure where you stand? Take the 3-minute readiness assessment
Direct answers
Pharmaceutical Manufacturing — common questions
Does Rowsys support FDA and EMA expectations for qualification documentation?
Yes. Rowsys structures qualification records the way inspectors expect to interrogate them — requirement to test to evidence, with Part 11 / Annex 11 compliant signatures and complete audit trails — and produces any trace on demand during an inspection.
Can Rowsys handle a multi-hundred-system facility qualification?
That is exactly the scale it is built for. The asset hierarchy, test matrices and dashboards are designed for programmes with hundreds of systems and thousands of protocols, with roll-ups that keep the picture legible at every level.
We are mid-project. Is it too late to adopt?
No. Teams frequently adopt Rowsys at the qualification stage of a running project, importing the existing requirement set, system list and completed-test status, and running the remainder of the programme on the thread.
See the method in practice
See Rowsys on a pharmaceutical scenario.
Bring your project — the demo runs on your kind of facility, your kind of systems, your kind of audit.